Vimarsana
Biggest News Aggregation in the World

Page 26 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heca Today - Breaking & Trending Today

Clene's ALS drug shows reduction in disease indicator levels in trial - Vimarsana News

Clene's ALS drug shows reduction in disease indicator levels in trial

Clene said on Thursday its experimental amyotrophic lateral sclerosis (ALS) drug showed reduction in levels of an indicator believed to be tied with the disease progression in a mid-stage trial.

Most Gulf markets gain ahead of Fed rate decision - Vimarsana News

Most Gulf markets gain ahead of Fed rate decision

Most stock markets in the Gulf ended higher on Wednesday as investors awaited the outcome of the U.S. Federal Reserve's monetary policy meeting.

US stocks drop after Fed signals more rate hikes to come - Vimarsana News

US stocks drop after Fed signals more rate hikes to come

U.S. stocks ended mixed on Wednesday after the Federal Reserve kept U.S. interest rates unchanged but signaled in new economic projections that borrowing costs will likely rise by another half of a percentage point by the end of this year.

UK police say three dead in incident in Nottingham - Vimarsana News

UK police say three dead in incident in Nottingham

British police said a man had been arrested on suspicion of murder after three people were found dead on the street in the central English city of Nottingham and three were in hospital after an attempt to run them over with a van.

Bunge, Viterra in $18 bln merger to create agriculture trading powerhouse - Vimarsana News

Bunge, Viterra in $18 bln merger to create agriculture trading powerhouse

U.S. grains merchant Bunge and Glencore -backed Viterra are merging to create an agricultural trading giant worth about $34 billion including debt, the companies said on Tuesday, in a deal that will likely draw close regulatory scrutiny.